We are developing highly integrated and miniaturized biosystems and nanomaterial synthesis platforms by taking advantage of microfluidic technology. Our research is aimed at applications in both biomedicine and chemistry, to solve the problem of rapid diagnosis of infectious diseases such as SARS-CoV-2 and automatic micro-scale synthesis of novel nanomaterials. The major research interests include microfluidic devices, smartphones, internet-of-things-based genetic analyzers, droplet generators, and microfluidic-based nanomaterial synthesis integrated feedback control